Transaction creates the nation’s largest independent urological services provider
NEW YORK (January 12, 2021) -- Solaris Health, a partnership formed by New York-based Integrated Medical Professionals (“IMP”) and Cincinnati-based The Urology Group (“TUG”), has joined forces with The Centers for Advanced Urology, LLP (“MidLantic Urology”), the leading urological services provider in the Philadelphia metropolitan area. The addition of MidLantic Urology to the Solaris Health platform positions Solaris as the nation’s leading independent provider of urological and other specialty services in the country. The partnership aligns the skills and talents of over 220 providers who have upwards of 850,000 patient encounters a year at more than 100 sites in New York, Ohio, Pennsylvania, Kentucky, and Indiana.
Deepak A. Kapoor, M.D., Chairman and Chief Ecosystem Officer, and Gary Kirsh, M.D., President of Solaris Health, founded Solaris with a shared vision to build the preeminent national urology practice in the country, providing the highest quality care. MidLantic Urology enthusiastically shares in this vision. By joining IMP and TUG, MidLantic Urology, led by its Executive Committee, Drs. Laurence Belkoff, David J. Ellis, Michael Hagg, and Brian Rosenthal, will play a major role in advancing Solaris.
“We are excited to partner with the high caliber team at MidLantic Urology,” said Drs. Kapoor and Kirsh. “The addition of MidLantic to the Solaris platform is a major step forward as we build a national urology practice of scale that can both elevate patient care and enhance the ability of urologists across the country to navigate the challenges of our evolving healthcare system.”
“MidLantic Urology is thrilled to partner with our highly regarded, long-term industry colleagues at IMP and TUG,” said Dr. Ellis, speaking on behalf of the MidLantic Executive Committee. “We share their vision of building the leading national urology network by providing physicians with state-of-the-art technology, clinical pathways, and unparalleled collaborative opportunities in order to deliver the highest quality care to our patients.”
“The MidLantic Urology partnership further solidifies our foundational platform, which is well positioned for continued growth,” said Eric Mason, MD, MBA, Solaris Health CEO. “The MidLantic Urology team is a natural fit due to its regional leadership, shared commitment to high quality, and innovative healthcare.”
“We are proud to have supported Drs. Kapoor and Kirsh and the broader Solaris team, who have done an incredible job of growing the business into a clear market leader over a brief period of time,” said Mark Gormley, Partner at Lee Equity, the investment partner of Solaris Health. “We look forward to supporting the Solaris Health management team to drive the next phase of its growth and continue to recruit industry-leading physicians to the partnership.”
Learn more at www.solarishealthpartners.com.
Terms have not been disclosed.
# # #
About Solaris Health
Solaris Health is a leading national healthcare platform committed to enhancing access to specialty healthcare and continually improving patient outcomes. Empowering community providers allows us to make sure that every decision we make puts patient care at the forefront. We are growing to meet the changing needs of the healthcare providers, and to develop innovative ways to better deliver value and state-of-the-art care to our patients. Now with more than 220 providers exceeding 850,000 patient encounters annually, Solaris Health is proud to be among the most innovative medical organizations in the United States. Visit www.solarishealthpartners.com.
About MidLantic Urology
Headquartered in Philadelphia, Pennsylvania, MidLantic Urology is a state-of-the-art urologic care provider that embraces independent practice, innovation, and research to improve patient outcomes. Our world-class physicians set new standards in comprehensive urologic patient care, engaging in pioneering research and establishing nationally recognized centers of excellence focused on prostate cancer, kidney stones, and female pelvic medicine. Visit www.midlanticurology.com.
About Lee Equity Partners
Lee Equity Partners is a New York-based private equity firm that partners with successful management teams to build companies with strong growth potential. Lee Equity targets equity investments of $50 million to $100 million in middle-market control buyouts and growth capital financings in companies with enterprise values of $100 million to $500 million that are located primarily in the United States. The firm invests in a range of industries where the team has deep relationships developed over decades, including business services, financial services, and healthcare services. Visit www.LeeEquity.com.